)
Edge12 Jun 2026
Set in Stone: The Story of Richemont
From a South African tobacco company to Cartier, a deep dive into how Richemont built one of the world's leading hard luxury empires.
Forte Biosciences
Forte Biosciences (FBRX) investor relations material
Forte Biosciences Registration filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Registration filing summary8 Jun, 2026
Company overview and business model
Clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases.
Lead product candidate FB102 is an anti-CD122 monoclonal antibody targeting key immune pathways.
FB102 has shown promising in-vitro and in-vivo results, including significant inhibition of T and NK cell proliferation and activation.
Ongoing clinical programs include Phase 1b and Phase 2 trials in celiac disease, vitiligo, and alopecia areata.
FB102 may have broader applications in diseases such as type 1 diabetes.
Financial performance and metrics
No dividends have been paid and there are no current plans to pay dividends.
The company qualifies as a smaller reporting company, allowing for reduced disclosure requirements.
Use of proceeds and capital allocation
Net proceeds from securities sales will be used at management's discretion, with specific uses detailed in future prospectus supplements.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Forte Biosciences
- Shelf registration enables up to $500M in offerings to fund autoimmune drug development.FBRX
Registration filing2 Jun 2026 - FB102 won FDA Fast Track, posted $22.1M Q1 loss, and raised $172.5M to fund clinical trials.FBRXQ1 202611 May 2026
- Key votes include director elections, auditor ratification, say-on-pay, and equity plan expansion.FBRXProxy filing29 Apr 2026
- FB102 clinical trials progress, R&D costs surge, and net loss widens amid strong cash position.FBRXQ4 20251 Apr 2026
- Registering 9.5M shares for resale post-$53M private placement; focus on autoimmune therapies.FBRXRegistration Filing16 Dec 2025
- Shelf registration enables up to $300M in offerings to fund autoimmune drug development.FBRXRegistration Filing16 Dec 2025
- Shareholders will vote on director elections, auditor ratification, an equity plan, and a reverse stock split.FBRXProxy Filing1 Dec 2025
- Shareholders will vote on director elections, auditor ratification, equity plan expansion, and a reverse stock split.FBRXProxy Filing1 Dec 2025
- 2025 proxy covers director elections, auditor ratification, and performance-linked executive pay.FBRXProxy Filing1 Dec 2025
Next Forte Biosciences earnings date
Q2 202614 Aug, 2026
Forte Biosciences
Next Forte Biosciences earnings date
Q2 202614 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage